An investment firm has expanded its New Jersey life sciences portfolio with the acquisition of a research facility in Somerset County, in a transaction arranged by Newmark Knight Frank.
The buyer of a seven-building, 768,244-square-foot portfolio in Somerset County has secured $41 million in financing, brokers with Cushman & Wakefield announced Tuesday.
